Skip to content
Peptide research

GHK-Cu

Also known as Copper Peptide
Category
Skin & Cosmetic
Administration routes
InjectableTopical
Regulatory status
Not FDA-approved

What it is

The copper-bound form of the GHK tripeptide, marketed for skin rejuvenation, wound healing, hair growth, and tissue repair. The strongest cases, skin and wound healing, rest mostly on topical and lab studies with thin human data, while hair growth, neuroprotection, and DNA repair are speculative. Injectable research-grade supply is unregulated and of uncertain purity, and best avoided in Wilson disease and copper allergy. Not an approved drug in the US.

Read Full record

Studied uses & evidence

Studied uses(7)

  • Skin rejuvenation

    Medium

    Small human studies show collagen induction and reduced wrinkle volume, with mixed objective results.

  • Wound healing

    Medium

    The 64.5% versus 28.2% result came from rats. Human topical wound evidence is limited; post-laser objective outcomes were negative.

  • Anti-inflammatory/antioxidant

    Low

    Boosts antioxidant enzymes and cuts lipid peroxidation, but evidence is largely lab-based.

Evidence limits

Evidence Level
Limited Clinical

Multiple placebo-controlled studies confirm wrinkle reduction, skin improvement. RCT (n=40): 55.8% wrinkle volume reduction. Finkley (n=67): improvements across all skin parameters. Miller RCT: no significant objective post-laser benefit; patient-reported satisfaction was higher. Human safety evidence is limited, particularly for injections.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

Do not use if

  • Wilson's disease

    Absolute

    Copper accumulation disorder. Additional copper delivery is dangerous.

  • Copper sensitivity/allergy

    High

    Contains copper. Can cause local reactions in sensitive individuals.

  • Active cancer

    Moderate

    GHK-Cu stimulates blood vessel growth and cell proliferation, which may promote tumor growth.

Risk summary(5)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Contraindicated in Wilson disease (genetic copper overload)

    Moderate
  • Contraindicated in copper allergy

    Moderate
  • Insufficient safety data for pregnancy/breastfeeding

    Moderate
  • Injectable forms unregulated; quality risks

    High
  • Long-term systemic effects of exogenous copper peptide not fully studied

    Moderate
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.